• PacBio at JPM 2026: Clinical Momentum and SPRQ-Nx Economics

    Bio-IT World | PacBio president Christian Henry presented at the 44th Annual J.P. Morgan Healthcare Conference with strong fourth quarter growth, breakthrough clinical adoption, and economics that position long-read sequencing as competitive with short reads.

    Jan 13, 2026

  • Oxford Nanopore at JPM 2026: Passing the Baton on a 20-Year Journey

    Bio-IT World | Gordon Sanghera, CEO, presented on behalf of Oxford Nanopore Technologies at the 44th Annual J.P. Morgan Healthcare Conference this week in San Francisco. In what he described as his final appearance at JPM as CEO, Sanghera reflected on 20 years of building a company around single-molecule electronic sensing while outlining a growth trajectory that saw the company exceed expectations in 2025.

    Jan 12, 2026

  • NVIDIA Bets Big on AI-Driven Drug Discovery, Physical AI, and a $1 Billion Eli Lilly Partnership

    Bio-IT World | NVIDIA is making a massive push into healthcare and life sciences, announcing a landmark five-year, $1 billion strategic partnership with pharmaceutical giant Eli Lilly alongside major expansions of its biological AI platform at the 2026 J.P. Morgan Healthcare Conference.

    Jan 12, 2026

  • TechBio Survey Shows a Mixed Industry Outlook, Claude Gaining Ground, More Machine Learning

    Bio-IT World | The Bits in Bio Slack-first community has released its fourth annual State of TechBio survey results. Year over year findings include a jump in Claude usage, an increase in daily machine learning work, and a serious cooling of the “Very bullish" sentiment across the broader biotech market.

    Jan 9, 2026

  • Systems Biology Map for Advancing the Translation of Extracellular Vesicles

    Bio-IT World | Extracellular vesicles (EVs) are the master communicators of multicellular life, key in orchestrating the complex signaling networks that define physiology. A new multiomics study has now revealed their molecular cargo via EVMap, a high-resolution blueprint of the proteins and lipids in human circulating EVs providing a practical pathway forward across basic, translational and clinical applications.

    Jan 7, 2026

  • Insilico Medicine’s IPO, Servier Pharma Deal

    Bio-IT World | On December 30, Insilico Medicine successfully listed on the Hong Kong Stock Exchange. This initial public offering (IPO) raised a total of HKD 2.277 billion ($292 billion), achieving the largest biotech IPO in Hong Kong in 2025.

    Jan 6, 2026

  • Trendspotting: Artificial Intelligence, Impact of Global Policies, Data Harmonization

    Bio-IT World | To kick off 2026, we spoke with industry experts and leaders in the Bio-IT World community about what they expect and look forward to in the new year. Here are the full trends and predictions, including more on AI, drug development, global policies, cancer treatments, and more.

    Jan 6, 2026